Vascular Imaging abnormalities and cognition: Mediation by cortical volume in nondemented individuals: Atherosclerosis risk in communities-neurocognitive study

Stroke

Volumn 46, Issue 2, 2015, Pages 433-440

  Knopman, David S ^a   Griswold, Michael E ^b   Lirette, Seth T ^b   Gottesman, Rebecca F ^c   Kantarci, Kejal ^a   Sharrett, A Richey ^c   Jack, Clifford R ^a   Graff Radford, Jonathan ^a   Schneider, Andrea L C ^c   Windham, B Gwen ^b   Coker, Laura H ^d,f   Albert, Marilyn S ^c   Mosley, Thomas H ^b   Coresh, Josef ^c   Roche, Karen Bandeen ^c   Selnes, Ola A ^c   McKhann, Guy ^c   Alonso, Alvaro ^e   Folsom, Aaron R ^e   Eckfeldt, John ^e   Wagenknecht, Lynne E ^f   Heiss, Gerardo ^g   Couper, David ^g   Wruck, Lisa ^g   more..

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f WAKE FOREST UNIVERSITY   (United States)

^g UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

cerebral infarction; cerebral small vessel diseases; cognition; magnetic resonance imaging

Indexed keywords

AFRICAN AMERICAN; AGED; ARTICLE; ATHEROSCLEROSIS; BRAIN INFARCTION; BRAIN SIZE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COGNITION; CONTROLLED STUDY; DISEASE ASSOCIATION; EXECUTIVE FUNCTION; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; IMAGING SOFTWARE; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; QUANTITATIVE ANALYSIS; WHITE MATTER; WHITE MATTER HYPERINTENSITY; WHITE MATTER INFARCTION; WHITE MATTER LESION; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; COHORT ANALYSIS; DEMOGRAPHY; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; COHORT STUDIES; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; RESIDENCE CHARACTERISTICS; RISK FACTORS;

EID: 84922325808     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.007847     Document Type: Article

References (59)

1. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968;114:797-811.
2. Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69:2197-2204. doi: 10.1212/01. wnl.0000271090.28148.24.
3. Sonnen JA, Santa Cruz K, Hemmy LS, Woltjer R, Levervenz JB, Montine KS, et al. Ecology of the aging human brain. Arch Neurol. 2011;68:1049-1056. doi: 10.1001/archneurol.2011.157.
4. Knopman D, Parisi JE, Boeve BF, Rocca WA, Cha RH, Apaydin H, et al. Vascular dementia in a population-based autopsy study. Arch Neurol 2003;60:569-76.
5. Esiri MM, Wilcock GK, Morris JH. Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry. 1997;63:749-753.
6. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348:1215-1222. doi: 10.1056/NEJMoa022066.
7. Carey CL, Kramer JH, Josephson SA, Mungas D, Reed BR, Schuff N, et al. Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly. Stroke. 2008;39:397-402. doi: 10.1161/STROKEAHA.107.491795.
8. Saczynski JS, Sigurdsson S, Jonsdottir MK, Eiriksdottir G, Jonsson PV, Garcia ME, et al. Cerebral infarcts and cognitive performance: importance of location and number of infarcts. Stroke. 2009;40:677-682. doi: 10.1161/STROKEAHA.108.530212.
9. van der Flier WM, van Straaten EC, Barkhof F, Verdelho A, Madureira S, Pantoni L, et al. Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study. Stroke. 2005;36:2116-2120. doi: 10.1161/01.STR.0000179092.59909.42.
10. Jokinen H, Gouw AA, Madureira S, Ylikoski R, van Straaten EC, van der Flier WM, et al; LADIS Study Group. Incident lacunes influence cognitive decline: the LADIS study. Neurology. 2011;76:1872-1878. doi: 10.1212/WNL.0b013e31821d752f.
11. Carmichael O, Schwarz C, Drucker D, Fletcher E, Harvey D, Beckett L, et al; Alzheimer's Disease Neuroimaging Initiative. Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative. Arch Neurol. 2010;67: 1370-1378. doi: 10.1001/archneurol.2010.284.
12. Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Koudstaal PJ, Oudkerk M, et al. Cerebral white matter lesions and the risk of dementia. Arch Neurol. 2004;61:1531-1534. doi: 10.1001/archneur.61.10.1531.
13. Murray ME, Senjem ML, Petersen RC, Hollman JH, Preboske GM, Weigand SD, et al. Functional impact of white matter hyperintensities in cognitively normal elderly subjects. Arch Neurol. 2010;67:1379-1385. doi: 10.1001/archneurol.2010.280.
14. Smith EE, Salat DH, Jeng J, McCreary CR, Fischl B, Schmahmann JD, et al. Correlations between MRI white matter lesion location and executive function and episodic memory. Neurology. 2011;76:1492-1499. doi: 10.1212/WNL.0b013e318217e7c8.
15. Kövari E, Gold G, Herrmann FR, Canuto A, Hof PR, Bouras C, et al. Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia. Neurology. 2007;68:927-931. doi: 10.1212/01. wnl.0000257094.10655.9a.
16. Smith EE, Schneider JA, Wardlaw JM, Greenberg SM. Cerebral microinfarcts: the invisible lesions. Lancet Neurol. 2012;11:272-282. doi: 10.1016/S1474-4422(11)70307-6.
17. Launer LJ, Hughes TM, White LR. Microinfarcts, brain atrophy, and cognitive function: the Honolulu Asia Aging Study Autopsy Study. Ann Neurol. 2011;70:774-780. doi: 10.1002/ana.22520.
18. White L. Brain lesions at autopsy in older Japanese-American men as related to cognitive impairment and dementia in the final years of life: a summary report from the Honolulu-Asia aging study. J Alzheimers Dis. 2009;18:713-725. doi: 10.3233/JAD-2009-1178.
19. Schneider AL, Sharrett AR, Gottesman RF, Coresh J, Coker L, Wruck L, et al. Normative data for 8 neuropsychological tests in older blacks and whites from the Atherosclerosis Risk in Communities (ARIC) study [published online ahead of print April 22, 2014]. Alzheimer Dis Assoc Disord. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=ovft&AN=00002093-900000000-99629&PDF=y. Accessed November 19, 2014.
20. Knopman DS, Mosley TH, Catellier DJ, Coker LH; Atherosclerosis Risk in Communities Study Brain MRI Study. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study. Alzheimers Dement. 2009;5:207-214. doi: 10.1016/j. jalz.2009.01.027.
21. Knopman DS, Penman AD, Catellier DJ, Coker LH, Shibata DK, Sharrett AR, et al. Vascular risk factors and longitudinal changes on brain MRI: the ARIC study. Neurology. 2011;76:1879-1885. doi: 10.1212/WNL.0b013e31821d753f.
22. Jack CR Jr, O'Brien PC, Rettman DW, Shiung MM, Xu Y, Muthupillai R, et al. FLAIR histogram segmentation for measurement of leukoaraiosis volume. J Magn Reson Imaging. 2001;14:668-676.
23. Raz L, Jayachandran M, Tosakulwong N, Lesnick TG, Wille SM, Murphy MC, et al. Thrombogenic microvesicles and white matter hyperintensities in postmenopausal women. Neurology. 2013;80:911-918. doi: 10.1212/WNL.0b013e3182840c9f.
24. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al; STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822-838. doi: 10.1016/S1474-4422(13) 70124-8.
25. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33:341-355.
26. Kantarci K, Weigand SD, Przybelski SA, Shiung MM, Whitwell JL, Negash S, et al. Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS. Neurology. 2009;72:1519-1525. doi: 10.1212/WNL.0b013e3181a2e864.
27. Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31:968-980. doi: 10.1016/j.neuroimage.2006.01.021.
28. Jones DT, Machulda MM, Vemuri P, McDade EM, Zeng G, Senjem ML, et al. Age-related changes in the default mode network are more advanced in Alzheimer disease. Neurology. 2011;77:1524-1531. doi: 10.1212/WNL.0b013e318233b33d.
29. Dickerson BC, Stoub TR, Shah RC, Sperling RA, Killiany RJ, Albert MS, et al. Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurology. 2011;76:1395-1402. doi: 10.1212/WNL.0b013e3182166e96.
30. Kuczynski B, Jagust W, Chui HC, Reed B. An inverse association of cardiovascular risk and frontal lobe glucose metabolism. Neurology. 2009;72:738-743. doi: 10.1212/01.wnl.0000343005.35498.e5.
31. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173-1182.
32. Rabe-Hesketh S, Skrondal A, Pickles A. Generalized multilevel structural equation modeling. Psychometrika. 2004;69:167-190.
33. Kloppenborg RP, Nederkoorn PJ, Grool AM, Vincken KL, Mali WP, Vermeulen M, et al; SMART Study Group. Cerebral small-vessel disease and progression of brain atrophy: the SMART-MR study. Neurology. 2012;79:2029-2036. doi: 10.1212/WNL.0b013e3182749f02.
34. Barnes J, Carmichael OT, Leung KK, Schwarz C, Ridgway GR, Bartlett JW, et al; Alzheimer's Disease Neuroimaging Initiative. Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls. Neurobiol Aging. 2013;34:1996-2002. doi: 10.1016/j.neurobiolaging.2013.02.003.
35. Appelman AP, Vincken KL, van der Graaf Y, Vlek AL, Witkamp TD, Mali WP, et al; SMART Study Group. White matter lesions and lacunar infarcts are independently and differently associated with brain atrophy: the SMART-MR study. Cerebrovasc Dis. 2010;29:28-35. doi: 10.1159/000255971.
36. Thong JY, Hilal S, Wang Y, Soon HW, Dong Y, Collinson SL, et al. Association of silent lacunar infarct with brain atrophy and cognitive impairment. J Neurol Neurosurg Psychiatry. 2013;84:1219-1225. doi: 10.1136/jnnp-2013-305310.
37. Mungas D, Jagust WJ, Reed BR, Kramer JH, Weiner MW, Schuff N, et al. MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Neurology. 2001;57:2229-2235.
38. den Heijer T, Launer LJ, Prins ND, van Dijk EJ, Vermeer SE, Hofman A, et al. Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe. Neurology. 2005;64:263-267. doi: 10.1212/01.WNL.0000149641.55751.2E.
39. Silbert LC, Quinn JF, Moore MM, Corbridge E, Ball MJ, Murdoch G, et al. Changes in premorbid brain volume predict Alzheimer's disease pathology. Neurology. 2003;61:487-492.
40. Jack CR Jr, Shiung MM, Weigand SD, O'Brien PC, Gunter JL, Boeve BF, et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology. 2005;65:1227-1231. doi: 10.1212/01.wnl.0000180958.22678.91.
41. Mungas D, Harvey D, Reed BR, Jagust WJ, DeCarli C, Beckett L, et al. Longitudinal volumetric MRI change and rate of cognitive decline. Neurology. 2005;65:565-571. doi: 10.1212/01. wnl.0000172913.88973.0d.
42. Ridha BH, Anderson VM, Barnes J, Boyes RG, Price SL, Rossor MN, et al. Volumetric MRI and cognitive measures in Alzheimer disease: comparison of markers of progression. J Neurol. 2008;255:567-574. doi: 10.1007/s00415-008-0750-9.
43. De Groot JC, De Leeuw FE, Oudkerk M, Van Gijn J, Hofman A, Jolles J, et al. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol. 2002;52:335-341. doi: 10.1002/ana.10294.
44. Debette S, Beiser A, DeCarli C, Au R, Himali JJ, Kelly-Hayes M, et al. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke. 2010;41:600-606. doi: 10.1161/STROKEAHA.109.570044.
45. Maillard P, Carmichael O, Fletcher E, Reed B, Mungas D, DeCarli C. Coevolution of white matter hyperintensities and cognition in the elderly. Neurology. 2012;79:442-448. doi: 10.1212/WNL.0b013e3182617136.
46. Schneider JA, Boyle PA, Arvanitakis Z, Bienias JL, Bennett DA. Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons. Ann Neurol. 2007;62:59-66. doi: 10.1002/ana.21142.
47. Gold G, Kövari E, Herrmann FR, Canuto A, Hof PR, Michel JP, et al. Cognitive consequences of thalamic, basal ganglia, and deep white matter lacunes in brain aging and dementia. Stroke. 2005;36:1184-1188. doi: 10.1161/01.STR.0000166052.89772.b5.
48. Longstreth WT Jr, Sonnen JA, Koepsell TD, Kukull WA, Larson EB, Montine TJ. Associations between microinfarcts and other macroscopic vascular findings on neuropathologic examination in 2 databases. Alzheimer Dis Assoc Disord. 2009;23:291-294. doi: 10.1097/WAD.0b013e318199fc7a.
49. Raman MR, Preboske GM, Przybelski SA, Gunter JL, Senjem ML, Vemuri P, et al. Antemortem MRI findings associated with microinfarcts at autopsy. Neurology. 2014;82:1951-1958. doi: 10.1212/WNL.0000000000000471.
50. Young VG, Halliday GM, Kril JJ. Neuropathologic correlates of white matter hyperintensities. Neurology. 2008;71:804-811. doi: 10.1212/01. wnl.0000319691.50117.54.
51. Murray ME, Vemuri P, Preboske GM, Murphy MC, Schweitzer KJ, Parisi JE, et al. A quantitative postmortem MRI design sensitive to white matter hyperintensity differences and their relationship with underlying pathology. J Neuropathol Exp Neurol. 2012;71:1113-1122. doi: 10.1097/NEN.0b013e318277387e.
52. Schneider JA, Wilson RS, Cochran EJ, Bienias JL, Arnold SE, Evans DA, et al. Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology. 2003;60:1082-1088.
53. Brundel M, de Bresser J, van Dillen JJ, Kappelle LJ, Biessels GJ. Cerebral microinfarcts: a systematic review of neuropathological studies. J Cereb Blood Flow Metab. 2012;32:425-436. doi: 10.1038/jcbfm.2011.200.
54. Duering M, Righart R, Csanadi E, Jouvent E, Hervé D, Chabriat H, et al. Incident subcortical infarcts induce focal thinning in connected cortical regions. Neurology. 2012;79:2025-2028. doi: 10.1212/WNL.0b013e3182749f39.
55. Lawrence AJ, Chung AW, Morris RG, Markus HS, Barrick TR. Structural network efficiency is associated with cognitive impairment in small-vessel disease. Neurology. 2014;83:304-311. doi: 10.1212/WNL.0000000000000612.
56. Lawrence AJ, Patel B, Morris RG, MacKinnon AD, Rich PM, Barrick TR, et al. Mechanisms of cognitive impairment in cerebral small vessel disease: multimodal MRI results from the St George's cognition and neuroimaging in stroke (SCANS) study. PLoS One. 2013;8:e61014. doi: 10.1371/journal.pone.0061014.
57. van Norden AG, van Uden IW, de Laat KF, van Dijk EJ, de Leeuw FE. Cognitive function in small vessel disease: the additional value of diffusion tensor imaging to conventional magnetic resonance imaging: the RUN DMC study. J Alzheimers Dis. 2012;32:667-676. doi: 10.3233/JAD-2012-120784.
58. Jokinen H, Lipsanen J, Schmidt R, Fazekas F, Gouw AA, van der Flier WM, et al; LADIS Study Group. Brain atrophy accelerates cognitive decline in cerebral small vessel disease: the LADIS study. Neurology. 2012;78:1785-1792. doi: 10.1212/WNL.0b013e3182583070.
59. Muller M, Appelman AP, van der Graaf Y, Vincken KL, Mali WP, Geerlings MI. Brain atrophy and cognition: interaction with cerebrovascular pathology? Neurobiol Aging. 2011;32:885-893. doi: 10.1016/j. neurobiolaging.2009.05.005.